GRATRONSET Report – Center for Nuclear Medicine and Oncology, Bach Mai Hospital, Hanoi

On the afternoon of June 7, 2019, at the Center for Nuclear Medicine and Oncology, Bach Mai Hospital, Hanoi, Medbolide Joint Stock Company had a report to introduce the product GRATRONSET (Granisetron 2mg) with the topic "Granisetron - Solution effective, safe and convenient treatment and prevention of nausea and vomiting. The report meeting gathered 40 doctors from the entire Center to attend.

Clinical research results showing the novelty, effectiveness, safety and convenience of Granisetron and the distinct advantages of GRATRONSET have been reported by representatives of Medbolide Company, attracting certain attention from medical professionals. Doctor. At the end of the presentation, there were many more proactive discussions by the Doctor about the product's indications and intended patients.

With the mission of improving the health quality of Vietnamese people, Medbolide Company hopes to continue accompanying doctors and patients with products with good treatment effects, bringing solutions to patients. cancer in particular and other diseases in general.